EndoWeld™ Revolutionizing Root Canal Therapy
EndoWeld™ — A Saudi-Swiss Innovation Redefining Root Canal Therapy
From university research to clinical reality, EndoWeld brings the world’s first ultrasonic obturation system to life.ult.
CLINICALLY PROVEN ADVANTAGES
Superior Adaptation
Reaches areas traditional methods cannot access
Enhanced Patient Comfort
Reduces chair time and post-treatment discomfort
Exceptional Sealing
Eliminates microleakage for better long-term outcomes
Preserves Tooth Structure
Less invasive approach maintains tooth integrity
Evidence
- Ex-vivo micro-CT studies show a 40–75 % reduction in voids compared to conventional techniques.
- Thermal profiling confirmed temperatures below 45 °C during activation.
- Demonstrated adaptation into lateral canals without compromising tooth structure.
BACKED BY SCIENCE, PROTECTED BY PATENTS
Our innovation is secured by international patents:
* US 10,898,295 B1 (2021)
* US 11,957,529 B2 (2024)
* SA 14693 B1 (2024)
In 2025, we filed three additional U.S. applications covering bioactive compositions and an integrated ultrasonic obturation system — expanding our IP portfolio and ensuring durable freedom to operate.
Developed through years of meticulous research and comprehensive laboratory testing, EndoWeld represents a true paradigm shift in endodontic treatment.